-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$979.67-6.76% Downside
Recent Analyst Forecasts and Stock Ratings
Regeneron Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. has been rated by research analysts at Truist Financial, Leerink Partners, Robert W. Baird, Goldman Sachs, BMO Capital, RBC Capital in the past 90 days.